Prognosis of radiotherapy in medullary thyroid carcinoma patients without distant metastasis

Background Medullary thyroid carcinoma (MTC) is an advanced disease with a poor prognosis. Although radiotherapy is widely utilized to treat MTC, it is still controversial. MTC patients without distant metastases have not been investigated to explore indications for adjuvant radiotherapy. This study aims to investigate the impact of radiotherapy on the survival of MTC patients without distant metastases. Methods Data of MTC patients without distant metastasis who underwent total thyroidectomy between 2010 and 2015 were obtained from the Surveillance, Epidemiology and End Results (SEER) database. Propensity score matching was performed to analyze the relationship between radiotherapy and cancer-specific survival (CSS). Results Seventy-four of 718 MTC patients without distant metastases received radiotherapy and underwent total thyroidectomy. A total of 148 patients were screened via propensity score matching analysis. Multivariate Cox regression indicated that factors including age, sex, radiotherapy and chemotherapy were independent predictors of CSS. Based on these factors, MTC patients without distant metastasis were classified into two risk groups using a nomogram and risk classification system. The C-index of the nomogram was 0.791. The calibration curves showed good consistency of CSS between the actual observation and the nomogram prediction, and decision curve analysis (DCA) showed great clinical usefulness of the nomogram. The three-year CSS of the radiotherapy group was 85.3%, and that of the surgery group was 95%. Particularly, compared with the surgery group, the three-year CSS of subgroups of the radiotherapy group, including male patients and those aged >48 years, was decreased. Conclusions Radiotherapy results in worse CSS for MTC patients without distant metastases. To maximize benefits, decisions about individual radiotherapy should weigh its advantages and disadvantages.

[1]  T. Hoang,et al.  Diagnostic Challenges of Medullary Thyroid Carcinoma , 2021, Oncology.

[2]  Michelle D. Williams,et al.  Neoadjuvant selpercatinib for advanced medullary thyroid cancer , 2020, Head & neck.

[3]  B. Jarzab,et al.  Current status of the prognostic molecular markers in medullary thyroid carcinoma , 2020, Endocrine connections.

[4]  Lin Qi,et al.  Predictors and Survival of Patients with Osteosarcoma After Limb Salvage versus Amputation: A Population-Based Analysis with Propensity Score Matching , 2020, World Journal of Surgery.

[5]  A. Maia,et al.  Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives. , 2019, Endocrine-related cancer.

[6]  K. Pacak,et al.  Medullary Thyroid Carcinoma: An Update on Imaging , 2019, Journal of thyroid research.

[7]  N. Rowell The role of external beam radiotherapy in the management of medullary carcinoma of the thyroid: A systematic review. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  L. Boucai,et al.  Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence , 2018, The Journal of clinical endocrinology and metabolism.

[9]  S. Roman,et al.  Surgical management of medullary thyroid carcinoma , 2017, Updates in Surgery.

[10]  D. Kallogjeri,et al.  Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma. , 2016, JAMA otolaryngology-- head & neck surgery.

[11]  C. Haglund,et al.  Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma , 2016, Acta oncologica.

[12]  Douglas B. Evans,et al.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.

[13]  J. Kievit,et al.  Fewer Cancer Reoperations for Medullary Thyroid Cancer After Initial Surgery According to ATA Guidelines , 2015, Annals of Surgical Oncology.

[14]  C. Charnsangavej,et al.  Current update on medullary thyroid carcinoma. , 2013, AJR. American journal of roentgenology.

[15]  B. Mciver,et al.  A Role for Radiotherapy in the Management of Advanced Medullary Thyroid Carcinoma: the Mayo Clinic Experience , 2013, Rare tumors.

[16]  P. Schneider,et al.  Adjuvant external beam radiation for medullary thyroid carcinoma , 2010, Journal of surgical oncology.

[17]  D. Dequanter,et al.  [Medullary thyroid cancer: surgical results and prognostic factors]. , 2010, Revue Medicale de Liege.

[18]  S. Roman,et al.  Medullary Thyroid Cancer: Are Practice Patterns in the United States Discordant From American Thyroid Association Guidelines? , 2010, Annals of Surgical Oncology.

[19]  J. Moley,et al.  Current approaches to medullary thyroid carcinoma, sporadic and familial , 2006, Journal of surgical oncology.

[20]  K. Fife,et al.  Medullary thyroid cancer: the role of radiotherapy in local control. , 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  R. Tsang,et al.  Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. , 1996, Thyroid : official journal of the American Thyroid Association.

[22]  H. Gharib,et al.  Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. , 1992, Mayo Clinic proceedings.

[23]  R. K. Davis,et al.  Thyroid cancer: A computer-assisted review of 5287 cases , 1990, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[24]  N. Samaan,et al.  Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. , 1988, The Journal of clinical endocrinology and metabolism.

[25]  M. Schlumberger,et al.  External radiotherapy in thyroid cancers , 1985, Cancer.

[26]  M. Saad,et al.  Medullary Carcinoma of the Thyroid: A STUDY OF THE CLINICAL FEATURES AND PROGNOSTIC FACTORS IN 161 PATIENTS , 1984, Medicine.

[27]  A. Laprie,et al.  [Postoperative external beam radiotherapy for medullary thyroid carcinoma with high risk of locoregional relapse]. , 2016, Cancer Radiothérapie.

[28]  N. Sakamoto,et al.  Cancer-Specific Mortality and Competing Mortality in Patients with Head and Neck Squamous Cell Carcinoma: A Competing Risk Analysis , 2014, Annals of Surgical Oncology.

[29]  G. Tusnády,et al.  Markov model-based estimation of individual survival probability for medullary thyroid cancer patients , 2009, Pathology Oncology Research.

[30]  O. Schober,et al.  Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register , 2004, The clinical investigator.